Anika Therapeutics, Inc. - ANIK - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Anika Therapeutics, Inc. - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
ANIK	Nasdaq	2834	http://www.anikatherapeutics.com/	14.18 +0.15
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Anika Therapeutics, Inc. Nasdaq stocks posting largest volume increases - May 24th, 2013 4:04 pm Nasdaq stocks posting largest percentage increases - May 24th, 2013 4:04 pm Promising Data on ONCY's Reolysin - May 24th, 2013 2:10 pm Encouraging News for Peregrine Pharma - May 24th, 2013 9:10 am New Diagnostic Solution from Roche - May 24th, 2013 9:00 am Biogen Submits Plegridy BLA - May 23rd, 2013 2:30 pm XenoPort Candidate Disappoints - May 21st, 2013 2:40 pm July Options Now Available For Anika Therapeutics (ANIK) - May 20th, 2013 1:20 pm Biogen's Hemophilia BLA Accepted - May 20th, 2013 7:40 am SGEN's Adcetris under FDA Review - May 16th, 2013 1:30 pm Pediatric Approval for MDCO/BMY's Recothrom - May 15th, 2013 2:00 pm Amgen to Set Up JV in China - May 14th, 2013 2:20 pm ANIKA THERAPEUTICS INC Financials - May 11th, 2013 11:04 am Disappointing 1Q Earnings for IART - May 10th, 2013 8:25 am Wider-than-Expected Loss at Dynavax - May 7th, 2013 8:45 am ANIKA THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report - May 6th, 2013 7:36 am Anika Therapeutics' CEO Discusses Q1 2013 Results - Earnings Call Transcript - May 2nd, 2013 2:06 pm Anika Therapeutics Earnings Call scheduled for 9:00 am ET today - May 2nd, 2013 7:00 am ANIKA THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex - May 1st, 2013 9:07 pm Anika Therapeutics Reports First-Quarter 2013 Financial Results - May 1st, 2013 3:32 pm View All Current Headlines >>